Lumira-sponsored SPAC seeks $100m from Nasdaq IPO
LAVA Medtech Acquisition Corp, a special purpose acquisition corporation, has priced its initial public offering on the Nasdaq Global Market to raise $100 million.
LAVA Medtech Acquisition Corp, a special purpose acquisition corporation, has priced its initial public offering on the Nasdaq Global Market to raise $100 million.
Copyright PEI Media
Not for publication, email or dissemination